Home Innovation That Matters

Innovation That Matters

Inside Perspectives on Immunotherapy: An Interview with Advaxis CEO Daniel O’Connor

Advaxis Immunotherapies, led by President and CEO Daniel O’Connor, is developing a promising and versatile approach to immuno-oncology with its Listeria monocytogenes (Lm) antigen delivery system. Lm Technology™ shows the immune system how to identify and target tumors, weakens tumor defense mechanisms, and triggers...

Inside Perspectives on Cancer Immunotherapy: An Interview with Juno CEO Hans Bishop

Juno Therapeutics President and CEO Hans Bishop leads one of the most dynamic, pioneering companies in the field of cancer immunotherapy. He describes this exciting, new strategy for destroying cancer cells as transformational, and he predicts it eventually will become the standard of care,...

A Passion for Precision Medicines: How Three Start-ups Are Changing the Paradigm

By Hui Cai, Vice President of Corporate Alliances and Head of Corporate Communications, WuXi AppTec Troy Wilson jokes about time travel being the basis of his next company, and it’s with good reason. A serial entrepreneur, Troy has been remarkably productive over the last several...

Inside Perspectives on Cancer Immunotherapy: An Interview with MPM’s Christiana Bardon

Boston-based MPM Capital’s Christiana Bardon, M.D., describes immunotherapy as an exciting, transformative field in cancer treatment. She foresees dramatic improvements for patients over the next 10 years. “We’ve just turned the corner in terms of understanding the best modalities for fighting cancer,” Bardon explains. “Now...

Brave Science: Putting the ‘Hutzpah’ in Early-Stage Drug Discovery

By Rich Soll, SVP of Research Service Division at WuXi AppTec (@richsollwx) From developing new paradigms for early-stage drug discovery for rare and common diseases to fostering the convergence of peptide nanotechnology, and launching scientific experiments in space, Israeli biochemist Ehud Gazit is wearing many hats these days. In...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi NextCODE AI Points to New Therapeutic Approaches to Cardiovascular Disease...

We are thrilled about WuXi NextCODE's contribution of its artificial intelligence (AI) and sequencing teams to the discovery of a novel mechanism regulating how blood...